Clinical Trial Update: Plant-based Ingredient on Post Prandial Glucose in Type II Diabetes [NA]

View source ↗

Summary

A completed clinical trial evaluated a plant-based ingredient's effect on postprandial glucose in adults with type 2 diabetes, sponsored by Unilever R&D.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Plant-based ingredient (unspecified)

Snippet

Sponsor: Unilever R&D | Conditions: Diabetes Mellitus, Type 2 | NA | Status: COMPLETED